Adrenal Insufficiency as a Cause of Loss of Consciousness: A Case Study

AUTHORS

Fahimeh Soheilipour 1 , Mohammad Ahmadi 1 , * , Fatemeh Jesmi 1

1 Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, IR Iran

How to Cite: Soheilipour F, Ahmadi M, Jesmi F. Adrenal Insufficiency as a Cause of Loss of Consciousness: A Case Study, J Compr Ped. 2014 ; 5(2):e17738. doi: 10.17795/compreped-17738.

ARTICLE INFORMATION

Journal of Comprehensive Pediatrics: 5 (2); e17738
Published Online: May 10, 2014
Article Type: Case Report
Received: January 19, 2014
Revised: April 8, 2014
Accepted: April 19, 2014
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Introduction: The current study introduces a case with adrenal insufficiency that was suspected to have congenital adrenal hypoplasia because of undescended testis and failure to thrive due to muscle involvement.

Case Presentation: The patient was a 34-month-old boy who had loss of consciousness, hypotension, hypoglycemia, hyponatremia and hyperkalemia with severe failure to thrive, hyper pigmentation of mucosa, hypotonia and no hypospadias. He was resistant to serum therapy and responded to hydrocortisone. Laboratory study elucidated elevated levels of adrenocorticotropin (ACTH) and muscle enzymes, decreased serum cortisol levels.

Discussion: Adrenal hypoplasia congenita is a differential diagnosis for adrenal insufficiency. Undescended testis, especially in absence of hypospadiasis, is a clue to diagnose and treat this lethal disease.

Keywords

Adrenal Insufficiency Adrenal Hypoplasia, Congenital Loss of Consciousness

Copyright © 2014, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Introduction

Adrenal cortex is a vital organ secreting three different types of hormones: aldosterone, hydrocortisone, and dehydroepiandrosterone. Clinical manifestations of adrenal insufficiency vary based on the type of hormone and are categorized into acute, chronic and acute on chronic. Increased level of adrenocorticotropin (ACTH) causes hyperpigmentation of skin and mucosa. Congenital adrenal hyperplasia (CAH) is the most common type of adrenal insufficiency. Patients with salt wasting forms of classic CAH have hypotension, hypoglycemia, hyponatremia, and hyperkalemia (1). Adrenal hypoplasia is a rare form of adrenal insufficiency and classically causes failure to thrive. Electrolyte imbalance is more prominent than hypoglycemia duo to dominance of aldosterone deficiency rather than cortisol deficiency (2). It is not distinguishable from CAH only based on clinical findings. Here a 34-month-old boy case with adrenal insufficiency is introduced who was suspected to have adrenal hypoplasia congenital (AHC) because of undescended testis and failure to thrive due to muscle involvement. Genetic study is not included in this report.

2. Case Presentation

The patient was a 34-month-old boy, presented to us with vomiting, diarrhea and loss of consciousness. He had not diarrhea and vomiting, for a week. There was no sign and symptom of urinary or respiratory infection and patient was not febrile. His medical history included failure to thrive since he was six months old and developmental delay; He had not started walking, could sit with help at the time of his referral and used bi-syllabled words. His delivery was an elective cesarean section after a non-complicated term pregnancy. His parents had two other children and their first child had died at the age of 30 months, because of a disease with seizure, probably expired by similar disease. His parents were not relatives. In emergency department, he was severely dehydrated and had a Glasgow consciousness score of 10. His blood pressure was 60 mmHg with a heart rate of 135 beat/min. His skin and mucosa were hyperpigmented. His Z-score curve values of weight and height were between -2 and -3(Z-score = -2.4). Complete physical examination after hydration showed generalized hypotonia and symmetric deep tendon reflexes. In examination of genital organs no hypospadias existed and both testes were touched. Left testis was touched in inguinal canal. Patient was resuscitated by rapid infusion of 20 mL/kg of normal saline besides dextrose serum. There was no response to serum therapy, repeated for three times; therefore, dopamine infusion was added. After blood sampling hydrocortisone infusion was added.

Laboratory data in Table 1, especially low serum sodium and elevated potassium and hypoglycemia guided the authors to adrenal insufficiency. According to differential diagnosis of adrenal insufficiency, hydrocortisone was continued and these factors were re-measured in blood sample (Table 2). According to decreased muscle force, in spite of adequate resuscitation, the serum test results listed in Table 3 were examined.

Table 1. Lab Date: Hypoglycemia, Hyponatremia and Hyperkalemia Are Noted a
Laboratory TestValue/Unit
Blood sugar45 mg/dL
Na120 meq/L
K5.8 meq/L
AST132 U/L
ALT104 U/L
Alb4.5 g/dL
ESR36 mm/h
Hemoglobin9.6 g/dL
Platelets311 109/L
WBC7.5 109/L
Triglyceride141 mg/dL
Cholesterol173 mg/dL
pH7.34
PCO232.7 mmHg
HCO317 mM
PaO2104 mmHg
O2sat94%

aAbbreviations: Alb: albumin; ALT: alanine amino transferase; AST: aspartate amino transferase; ESR: erythrocyte sedimentation rate; sat: saturation; WBC: white blood cell.

Table 2. Elevated ACTH and Suppressed Serum Cortisol Recommended Adrenal Insufficiency Besides Clinical Findings
Laboratory TestValue/Unit
ACTH level> 2000 pmol/L
Serum cortisol4.4 ng/dL
Table 3. Elevated Muscle Enzymes After Stabilization
Laboratory TestValue/Unit
Creatinine phosphokinase5400 mg/dL
Lactate dehydrogenase1330 mg/dL

Elevated muscle enzymes were confirmed. Electromyography and conduction velocimetry revealed myopathic pattern with spontaneous opisthotonus in active phase. All of the above results guided the authors to a primary adrenal insufficiency and a myopathic process. Patient was treated with dextrose saline and stress dose of hydrocortisone; the treatment was continued by administration of increasing dose of drug in diseases and stressful conditions and the patient was discharged after tapering to 12 mg/m2/day hydrocortisone. After four months, he was able to walk and the growth parameters, weight and height, improved to z-scores between -1 and 0 (height Z-score = -0.5, weight Z score = -0.8). Hyper pigmentations subsided after six months. Now the patient is six years old and is able to walk and talk and has no crisis under treatment.

3. Discussion

Hypotension, hypoglycemia, hyponatremia, and hyperkalemia and mucosa hyperpigmentation guided the authors to a primary adrenal insufficiency. High level of serum ACTH and low level of serum cortisol confirmed the diagnosis. As a differential diagnosis to CAH, adrenal hypoplasia could be considered for this patient. Improvement in growth and developmental delay after corticosteroid replacement, demonstrated that the developmental delay was secondary to adrenal insufficiency. The only clue to differentiate this complication from CAH is that DAX-1 gene has an antitestis activity against sex determining region (3). Its deletion leads to bilateral or unilateral cryptorchidism. Undescended testes were prevalent in reported cases of congenital adrenal hypoplasia as the current case (4). It should be considered that ambiguous genitalia are definite signs, as well as hypospadias, besides undescended testis or bilateral undescended testes (5). Therefore the patient’s genitalia could not be considered ambiguous. He only had a unilateral undescended testis touched in inguinal canal. X-linked form of adrenal hypoplasia is caused by a deletion in DAX-1 gene within X chromosome and is associated with hypogonadotropic hypogonadism (6). Due to contiguous chromosome deletion, Duchene dystrophy and glycerol kinase deficiency may coexist. DAX-1 is a nuclear hormone receptor family without known ligand. It has an unknown role in adrenal cortex development. Autosomal recessive forms had been also reported, involving other genes (7). Some studies have reported occasional cases of AHC presenting dominantly with hyperpigmentation and failure to thrive. (8) Some have also reported late diagnosed cases of AHC at adulthood with lack of puberty and skeletal immaturity. (9) It is clinically vital to diagnose AHC, a rare syndrome, from the more prevalent syndrome CAH, when the signs and symptoms are not specific for AHC, as in the current case. To confirm the diagnosis and exclude CAH, it is necessary to analyze cortical steroids and evaluate DAX-1 gene deletion with karyotyping, fluorescent in situ hybridization or microarray analysis. Abdominal sonography in infants and computerized tomography scan in older children may also be helpful. A review on 16 cases of AHC has reported bone age acceleration by 60 months of life after corticosteroid therapy and has suggested close observation on these patients for exact follow-up of the treatment and comorbidities (8). In adrenal insufficiency, whether hyperplasia or hypoplasia, the critical point is early diagnosis and emergent replacement of hormones as the 2002 consensus statement has approved (10). Since clinical manifestations vary widely based on the genetic syndrome, confirming the net diagnosis through genetic consultation is vital in order to protect other kids of the family from the same disease and prevent lethal adrenal insufficiency crises. Yet, this question remains unanswered: How can his myopathy be explained? Can cortical hormones deficiency be responsible for that? Documentation of AHC or CAH diagnosis by genetic study, which was not possible for the current patient’s family, may be helpful to find the response. Adrenal hypoplasia congenita is a differential diagnosis for adrenal insufficiency. Undescended testis, especially in the absence of hypospadias, is a clue for diagnosis.

Acknowledgements

Footnotes

References

  • 1.

    Kelch R, Virdis R, Rappaport R, Greig F, Levine L, New M. Adrenal diseases in childhood: congenital adrenal hypoplasia. Pediatric and Adolescent Endocrinology. 1984; : 156 -61

  • 2.

    Campo S, Moteagudo C, Nicolau G, Pellizzari E, Belgorosky A, Stivel M, et al. Testicular function in prepubertal male pseudohermaphroditism. Clin Endocrinol (Oxf). 1981; 14(1) : 11 -22 [PubMed]

  • 3.

    Guo W, Burris TP, McCabe ER. Expression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axis. Biochem Mol Med. 1995; 56(1) : 8 -13 [PubMed]

  • 4.

    Li N, Liu R, Zhang H, Yang J, Sun S, Zhang M, et al. Seven novel DAX1 mutations with loss of function identified in Chinese patients with congenital adrenal hypoplasia. J Clin Endocrinol Metab. 2010; 95(9) -11 [DOI][PubMed]

  • 5.

    van der Zanden LF, van Rooij IA, Feitz WF, Franke B, Knoers NV, Roeleveld N. Aetiology of hypospadias: a systematic review of genes and environment. Hum Reprod Update. 2012; 18(3) : 260 -83 [DOI][PubMed]

  • 6.

    Weiss L, Mellinger RC. Congenital adrenal hypoplasia--an X-linked disease. J Med Genet. 1970; 7(1) : 27 -32 [PubMed]

  • 7.

    Cole DE, Clarke LA, Riddell DC, Samson KA, Seltzer WK, Salisbury S. Congenital adrenal hypoplasia, Duchenne muscular dystrophy, and glycerol kinase deficiency: importance of laboratory investigations in delineating a contiguous gene deletion syndrome. Clin Chem. 1994; 40(11 Pt 1) : 2099 -103 [PubMed]

  • 8.

    Battistin C, Menezes Filho HC, Domenice S, Nishi MY, Della Manna T, Kuperman H, et al. A novel DAX1/NR0B1 mutation in a patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Arq Bras Endocrinol Metabol. 2012; 56(8) : 496 -500 [PubMed]

  • 9.

    Fichna M, Zurawek M, Gut P, Sowinski J, Nowak J. Adrenal hypoplasia congenita - an uncommon reason of primary adrenal insufficiency. Ann Endocrinol (Paris). 2010; 71(4) : 309 -13 [DOI][PubMed]

  • 10.

    Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW, et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res. 2002; 58(4) : 188 -95 [PubMed]

  • COMMENTS

    LEAVE A COMMENT HERE: